
Results
2
2 companies
Revenio Group Oyj
Market Cap: €327.8m
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
REG1V
€12.32
7D
3.7%
1Y
-53.2%
Nexstim
Market Cap: €75.7m
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
NXTMH
€9.37
7D
-4.9%
1Y
-34.7%